Salarius Pharmaceuticals (NASDAQ:SLRX – Get Free Report) was upgraded by equities researchers at Wall Street Zen from a “sell” rating to a “hold” rating in a research note issued on Saturday. Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of Salarius Pharmaceuticals in a report on Thursday. One research analyst has rated the […]

Wall Street Zen upgraded shares of Creative Medical Technology (NASDAQ:CELZ – Free Report) to a hold rating in a research report released on Saturday. Other equities analysts have also recently issued reports about the company. Zacks Research upgraded Creative Medical Technology to a “hold” rating in a research report on Tuesday, August 12th. Weiss Ratings […]

Wall Street Zen lowered shares of Caris Life Sciences (NASDAQ:CAI – Free Report) from a buy rating to a hold rating in a report published on Saturday morning. Caris Life Sciences Price Performance CAI stock opened at $28.86 on Friday. Caris Life Sciences Company Profile (Get Free Report) We are a leading, patient-centric, next-generation AI […]